BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8566053)

  • 21. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
    Naparstek E; Ohana M; Greenberger JS; Slavin S
    Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
    Kedar E; Tsuberi BZ; Landesberg A; Anafi M; Leshem B; Gillis S; Urdal DL; Slavin S
    Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient natural defense mechanisms against Listeria monocytogenes in T and B cell-deficient allogeneic bone marrow radiation chimeras. Preactivated macrophages are the main effector cells in an early phase after bone marrow transfer.
    Roesler J; Gröttrup E; Baccarini M; Lohmann-Mattes ML
    J Immunol; 1989 Sep; 143(5):1710-5. PubMed ID: 2668412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing reconstitution by bone marrow transplantation.
    van Bekkum DW; Wielenga JJ; van Gils F; Wagemaker G
    Prog Clin Biol Res; 1990; 352():479-91. PubMed ID: 1698302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte colony-stimulating factor prior to nonmyeloablative irradiation decreases murine host hematopoietic stem cell function and increases engraftment of donor marrow cells.
    Barese C; Pech N; Dirscherl S; Meyers JL; Sinn AL; Yoder MC; Goebel WS; Dinauer MC
    Stem Cells; 2007 Jun; 25(6):1578-85. PubMed ID: 17347493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hematopoietic reconstitution in the allogeneic bone marrow chimeric mice].
    Fukuhara T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):616-23. PubMed ID: 3065194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice.
    Koda M; Nishio Y; Kamada T; Someya Y; Okawa A; Mori C; Yoshinaga K; Okada S; Moriya H; Yamazaki M
    Brain Res; 2007 May; 1149():223-31. PubMed ID: 17391650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells.
    Xu LH; Fang JP; Huang WG; Xu HG; Weng WJ; Kao GS; Le Y
    Bone Marrow Transplant; 2007 Oct; 40(7):691-8. PubMed ID: 17660838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of TLR2 expression on G-CSF-mobilized peripheral blood stem cells is responsible for their rapid engraftment after allogeneic hematopoietic stem cell transplantation.
    Joo YD; Lee WS; Won HJ; Lee SM; Choi JH; Lee SM; Han KH; Park SG; Choi IW; Seo SK
    Cytokine; 2011 Apr; 54(1):36-42. PubMed ID: 21239180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo administration of cytokine in allogeneic bone marrow chimeras.
    Imamura M; Fujimoto H; Hashino S; Fukuhara T; Kobayashi M; Kasai M; Sakurada K; Miyazaki T
    Immunobiology; 1990 Jun; 180(4-5):441-57. PubMed ID: 1697845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The early administration of granulocyte colony-stimulating factor increases the engraftment of transplanted bone marrow-derived cells into the olfactory epithelium damaged by methimazole.
    Nishizaki K; Yoshinobu J; Tsujigiwa H; Orita Y; Yamada M
    Rhinology; 2010 Jun; 48(2):228-32. PubMed ID: 20502766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute rejection of allogeneic hemopoietic progenitors by genetically resistant mice.
    Shimamura K; Kaminsky SG; Nakamura I
    Eur J Immunol; 1989 Jul; 19(7):1165-70. PubMed ID: 2569400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host F1 mice pretreated with granulocyte colony-stimulating factor accept parental bone marrow grafts in hybrid resistance system.
    Iizuka K; Kaneko H; Yamada T; Kimura H; Kokai Y; Fujimoto J
    Blood; 1997 Feb; 89(4):1446-51. PubMed ID: 9028969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.